BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17094574)

  • 1. [Role of minor histocompatibility antigens in hematopoietic cell transplantation].
    Akatsuka Y
    Rinsho Ketsueki; 2006 Oct; 47(10):1353-63. PubMed ID: 17094574
    [No Abstract]   [Full Text] [Related]  

  • 2. [Minor antigens - major impact. The role of minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation].
    Hudecek M; Bartsch K; Tschiedel S; Niederwieser D
    Dtsch Med Wochenschr; 2008 Jul; 133(28-29):1511-6. PubMed ID: 18597211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minor histocompatibility antigens: targets for tumour therapy and transplant tolerance.
    Spierings E
    Int J Immunogenet; 2008 Aug; 35(4-5):363-6. PubMed ID: 18976439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minor histocompatibility antigens: past, present, and future.
    Spierings E
    Tissue Antigens; 2014 Oct; 84(4):374-60. PubMed ID: 25262921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecules and mechanisms of the graft-versus-leukaemia effect.
    Bleakley M; Riddell SR
    Nat Rev Cancer; 2004 May; 4(5):371-80. PubMed ID: 15122208
    [No Abstract]   [Full Text] [Related]  

  • 6. [Possibility of selective induction of a GVL effect without increasing GVHD].
    Akatsuka Y
    Rinsho Ketsueki; 2008 Aug; 49(8):607-15. PubMed ID: 18800609
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy of cancer through targeting of minor histocompatibility antigens.
    Hambach L; Goulmy E
    Curr Opin Immunol; 2005 Apr; 17(2):202-10. PubMed ID: 15766682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relevance of minor histocompatibility antigens in solid organ transplantation.
    Dierselhuis M; Goulmy E
    Curr Opin Organ Transplant; 2009 Aug; 14(4):419-25. PubMed ID: 19444105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of minor histocompatibility antigens in GVHD and rejection: a mini-review.
    Goulmy E; Voogt P; van Els C; de Bueger M; van Rood J
    Bone Marrow Transplant; 1991; 7 Suppl 1():49-51. PubMed ID: 2043886
    [No Abstract]   [Full Text] [Related]  

  • 10. Domestic and foreign donor candidates result in differential probability of matching minor histocompatibility antigens--relevance of selection for hematopoietic stem cell transplantation.
    Turpeinen H; Volin L; Partanen J
    Tissue Antigens; 2009 Mar; 73(3):236-41. PubMed ID: 19254253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting alloreactive T cells to hematopoietic system specific minor histocompatibility antigens for cellular immunotherapy of hematological malignancies after stem cell transplantation.
    Mutis T; Goulmy E
    Ann Hematol; 2002; 81 Suppl 2():S38-9. PubMed ID: 12611070
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk assessment in haematopoietic stem cell transplantation: minor histocompatibility antigens.
    Hambach L; Spierings E; Goulmy E
    Best Pract Res Clin Haematol; 2007 Jun; 20(2):171-87. PubMed ID: 17448955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting haematopoietic-specific minor histocompatibility antigens to distinguish graft-versus-tumour effects from graft-versus-host disease.
    Spaapen R; Mutis T
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):543-57. PubMed ID: 18790454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of discordant sib-pair linkage analysis for mapping minor histocompatibility antigen loci in a novel graft-vs-host-disease model.
    Araki J; Ohashi J; Muramatsu M
    Tissue Antigens; 2004 Sep; 64(3):243-50. PubMed ID: 15304004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RE: Minor histocompatibility antigen HA-1 and HPA-5 polymorphisms in HLA-identical related bone marrow transplantation.
    Brickner AG
    Transplant Proc; 2005 Dec; 37(10):4640-1; author reply 4641. PubMed ID: 16387190
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cellular immunotherapy of hematologic malignancies attempted using minor histocompatibility antigens as targets].
    Takami A; Shiobara S
    Rinsho Ketsueki; 2002 May; 43(5):360-2. PubMed ID: 12096487
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenic disparities of 11 minor histocompatibility antigens (mHAs) in HLA-matched unrelated allogeneic hematopoietic SCT.
    Markiewicz M; Siekiera U; Karolczyk A; Szymszal J; Helbig G; Wojnar J; Dzierzak-Mietla M; Kyrcz-Krzemien S
    Bone Marrow Transplant; 2009 Feb; 43(4):293-300. PubMed ID: 18850018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism.
    den Haan JM; Meadows LM; Wang W; Pool J; Blokland E; Bishop TL; Reinhardus C; Shabanowitz J; Offringa R; Hunt DF; Engelhard VH; Goulmy E
    Science; 1998 Feb; 279(5353):1054-7. PubMed ID: 9461441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polymorphic adhesion molecules mediating the graft-versus-leukemia effect].
    Takami A; Nakao S
    Rinsho Ketsueki; 2004 Mar; 45(3):183-8. PubMed ID: 15103930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.